Loading...
XSHE
000423
Market cap4.96bUSD
Jun 03, Last price  
55.49CNY
1D
1.24%
1Q
-2.03%
Jan 2017
3.01%
Name

Dong-E-E-Jiao Co Ltd

Chart & Performance

D1W1MN
P/E
22.90
P/S
6.02
EPS
2.42
Div Yield, %
5.28%
Shrs. gr., 5y
-0.24%
Rev. gr., 5y
14.88%
Revenues
5.92b
+25.57%
938,172,2761,069,373,2631,381,360,6751,685,955,3112,079,106,0812,463,784,2682,758,848,2533,056,074,2634,016,304,4154,009,010,4685,449,663,1576,317,135,2867,372,340,3327,338,316,2232,958,622,3393,409,437,1643,848,985,6864,041,818,3474,715,265,7295,920,785,955
Net income
1.56b
+35.29%
109,691,712153,855,462205,804,808287,044,651392,123,976582,224,299856,166,1701,040,218,1411,202,878,2241,365,547,7901,625,027,0311,852,473,5182,044,352,5032,084,866,052043,289,251440,439,963779,998,1161,150,878,5501,557,000,775
CFO
2.17b
+11.13%
67,407,174311,882,903240,331,283296,834,367812,705,828635,765,908709,731,461858,044,198879,093,682657,105,721977,610,166624,572,5121,757,389,2101,009,049,0530800,834,1832,800,902,5282,144,878,1851,953,438,0092,170,810,025
Dividend
Sep 10, 20241.14669 CNY/sh
Earnings
Aug 20, 2025

Profile

Dong-E-E-Jiao Co.,Ltd. produces and sells traditional Chinese medicines, biological drugs, and health food products in China. Dong-E-E-Jiao Co.,Ltd. was founded in 1952 and is based in Liaocheng, China.
URL
https://www.dongeejiao.com/
IPO date
Jul 29, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
5,920,786
25.57%
4,715,266
16.66%
4,041,818
5.01%
Cost of revenue
3,529,795
3,120,865
2,795,800
Unusual Expense (Income)
NOPBT
2,390,991
1,594,401
1,246,018
NOPBT Margin
40.38%
33.81%
30.83%
Operating Taxes
298,819
210,945
132,788
Tax Rate
12.50%
13.23%
10.66%
NOPAT
2,092,172
1,383,456
1,113,231
Net income
1,557,001
35.29%
1,150,879
47.55%
779,998
77.10%
Dividends
(758,665)
(425,114)
Dividend yield
2.39%
1.62%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
24,029
Long-term debt
41,902
62,046
84,889
Deferred revenue
58,952
65,741
75,838
Other long-term liabilities
63,925
57,347
57,954
Net debt
(5,057,493)
(5,849,158)
(7,121,891)
Cash flow
Cash from operating activities
2,170,810
1,953,438
2,144,878
CAPEX
(54,450)
Cash from investing activities
(718,144)
589,508
Cash from financing activities
(778,982)
FCF
2,137,235
1,995,602
2,236,353
Balance
Cash
8,534,124
8,336,771
7,230,809
Long term investments
(3,434,728)
(2,425,568)
Excess cash
4,803,356
5,675,441
7,028,718
Stockholders' equity
9,548,275
9,874,090
10,002,832
Invested Capital
5,672,364
5,219,233
3,354,216
ROIC
38.42%
32.27%
28.35%
ROCE
22.82%
14.63%
12.00%
EV
Common stock shares outstanding
643,389
642,949
643,977
Price
62.72
27.17%
49.32
21.18%
40.70
-16.51%
Market cap
40,353,342
27.26%
31,710,240
20.99%
26,209,857
-16.51%
EV
35,317,568
25,882,630
19,109,513
EBITDA
2,544,172
1,758,246
1,413,253
EV/EBITDA
13.88
14.72
13.52
Interest
7,639
3,973
5,177
Interest/NOPBT
0.32%
0.25%
0.42%